<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EUR" hierarchy="2" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>BE-BCE_KBO-0410057701-PROG17-21_01OC2</iati-identifier>
  <reporting-org ref="BE-BCE_KBO-0410057701" type="15">
   <narrative xml:lang="EN">Instituut voor Tropische Geneeskunde</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">PROG17-21_01OC2_Rationaliser la lutte contre la Trypanosomiase Humaine Africaine (THA) en renfor&#xE7;ant les syst&#xE8;mes locaux de sant&#xE9; avec l&#x2019;appui de tous les partenaires</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Une action concert&#xE9;e du programme national avec l&#x2019;appui de l&#x2019;INRB (Institut National de Recherche Biom&#xE9;dicale), ESP (&#xC9;cole de Sant&#xE9; Publique) et CRS (Centre de Recherche Sanitaire de Kimpese) visant la rationalisation du contr&#xF4;le de la maladie du sommeil dans un contexte &#xE9;pid&#xE9;miologique qui tend vers l&#x2019;&#xE9;limination dans 90% des foyers en 2020. L&#x2019;approche se r&#xE9;sume en trois axes strat&#xE9;giques: 1.l&#x2019;alignement sur la r&#xE9;forme du secteur sant&#xE9; en cours en RD Congo et donc un ancrage fort de la planification op&#xE9;rationnelle dans celle des Divisions Provinciales de Sant&#xE9; et les Equipes Cadre de District ; 2. l&#x2019;adoption de nouvelles technologies, y compris les outils digitaux ;3.une ouverture sur la lutte contre les autres Maladies Tropicales N&#xE9;glig&#xE9;es.</narrative>
  </description>
  <participating-org activity-id="XM-DAC-2-10-1111" ref="XM-DAC-2-10" role="1" type="10">
   <narrative xml:lang="EN">Belgian Development Cooperation</narrative>
  </participating-org>
  <participating-org role="4" type="22">
   <narrative xml:lang="EN">Institut M&#xE9;dical Evang&#xE9;lique</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">Institut National de Recherche Biom&#xE9;dicale</narrative>
  </participating-org>
  <participating-org activity-id="BE-BCE_KBO-0410057701-PROG17-21_01OC2" ref="BE-BCE_KBO-0410057701" role="2" type="80">
   <narrative xml:lang="EN">Instituut voor Tropische Geneeskunde</narrative>
  </participating-org>
  <participating-org activity-id="BE-BCE_KBO-0410057701-PROG17-21_01OC2" ref="BE-BCE_KBO-0410057701" role="4" type="80">
   <narrative xml:lang="EN">Instituut voor Tropische Geneeskunde</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">Programme National de Lutte contre la Trypanosomiase Humaine Africaine</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">Universit&#xE9; de Lubumbashi - Ecole de Sant&#xE9; Publique</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2017-01-01" type="1"></activity-date>
  <activity-date iso-date="2017-01-01" type="2"></activity-date>
  <activity-date iso-date="2021-12-31" type="3"></activity-date>
  <activity-date iso-date="2021-12-31" type="4"></activity-date>
  <contact-info type="1">
   <department>
    <narrative xml:lang="EN">Project Management</narrative>
   </department>
   <email>dgdprojectenbeheer@itg.be</email>
  </contact-info>
  <recipient-country code="CD" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="2314302" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="FR">Kinshasa</narrative>
   </name>
   <administrative code="2314302" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-4.36832042087623 15.2490234375</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
   <feature-designation code="PPLC"></feature-designation>
  </location>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="2314523" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="FR">Kimpese</narrative>
   </name>
   <administrative code="2314523" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-5.553114267439087 14.414062499999998</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
   <feature-designation code="PPL"></feature-designation>
  </location>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="922704" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="FR">Lubumbashi</narrative>
   </name>
   <administrative code="922704" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-11.662996112308035 27.498779296875</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
   <feature-designation code="PPLA"></feature-designation>
  </location>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="1" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="1" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="1" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="30"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2017-01-01"></period-start>
   <period-end iso-date="2017-12-31"></period-end>
   <value currency="EUR" value-date="2017-01-01">2167798.49</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2018-01-01"></period-start>
   <period-end iso-date="2018-12-31"></period-end>
   <value currency="EUR" value-date="2018-01-01">2469519.88</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="EUR" value-date="2019-01-01">2802105.55</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="EUR" value-date="2020-01-01">2310859.26</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="EUR" value-date="2021-01-01">4896976.66</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-01-01"></transaction-date>
   <value currency="EUR" value-date="2017-01-01">2007728.79</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut M&#xE9;dical Evang&#xE9;lique</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-12-31"></transaction-date>
   <value currency="EUR" value-date="2017-12-31">125445.37</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut M&#xE9;dical Evang&#xE9;lique</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-12-31"></transaction-date>
   <value currency="EUR" value-date="2018-12-31">285966.06</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut M&#xE9;dical Evang&#xE9;lique</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="EUR" value-date="2019-12-31">372597.5</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut M&#xE9;dical Evang&#xE9;lique</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="EUR" value-date="2020-12-31">484312.14</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut M&#xE9;dical Evang&#xE9;lique</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="EUR" value-date="2021-12-31">262932.49</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut M&#xE9;dical Evang&#xE9;lique</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-12-31"></transaction-date>
   <value currency="EUR" value-date="2017-12-31">24866.81</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut National de Recherche Biom&#xE9;dicale</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-12-31"></transaction-date>
   <value currency="EUR" value-date="2018-12-31">28903.7</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut National de Recherche Biom&#xE9;dicale</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="EUR" value-date="2019-12-31">45461.86</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut National de Recherche Biom&#xE9;dicale</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="EUR" value-date="2021-12-31">41301.82</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut National de Recherche Biom&#xE9;dicale</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-01-01"></transaction-date>
   <value currency="EUR" value-date="2017-01-01">3865288.76</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Programme National de Lutte contre la Trypanosomiase Humaine Africaine</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-12-31"></transaction-date>
   <value currency="EUR" value-date="2017-12-31">925071.53</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Programme National de Lutte contre la Trypanosomiase Humaine Africaine</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-12-31"></transaction-date>
   <value currency="EUR" value-date="2018-12-31">813000</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Programme National de Lutte contre la Trypanosomiase Humaine Africaine</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="EUR" value-date="2019-12-31">863181.63</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Programme National de Lutte contre la Trypanosomiase Humaine Africaine</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="EUR" value-date="2020-12-31">319924.14</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Programme National de Lutte contre la Trypanosomiase Humaine Africaine</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="EUR" value-date="2021-12-31">595664.47</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Programme National de Lutte contre la Trypanosomiase Humaine Africaine</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-01-01"></transaction-date>
   <value currency="EUR" value-date="2017-01-01">116763.3</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701"></provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institut National de Recherche Biom&#xE9;dicale</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="EUR" value-date="2020-12-31">53516.49</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701"></provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut National de Recherche Biom&#xE9;dicale</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="EUR" value-date="2020-12-31">689444.9</value>
   <provider-org type="15"></provider-org>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-12-31"></transaction-date>
   <value currency="EUR" value-date="2017-12-31">763140.52</value>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-12-31"></transaction-date>
   <value currency="EUR" value-date="2018-12-31">568816.54</value>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="EUR" value-date="2019-12-31">1293226.07</value>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="EUR" value-date="2021-12-31">2881293.16</value>
  </transaction>
  <related-activity ref="BE-BCE_KBO-0410057701-PROG17-21" type="1"></related-activity>
  <conditions attached="0"></conditions>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="FR">Rationaliser la lutte contre la Trypanosomiase Humaine Africaine (THA) en renfor&#xE7;ant les syst&#xE8;mes locaux de sant&#xE9; avec l&#x2019;appui de tous les partenaires</narrative>
   </title>
   <indicator aggregation-status="0" ascending="1" measure="5">
    <title>
     <narrative xml:lang="FR">Contexte &#xE9;pid&#xE9;miologique et financier</narrative>
    </title>
    <description>
     <narrative xml:lang="FR"></narrative>
    </description>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="FR">Le Programme et budget ne sont pas encore adapt&#xE9; au nouveau contexte &#xE9;pid&#xE9;miologique et financier</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="FR">Le Plan d&#x2019;Action Strat&#xE9;gique est mis en &#x153;uvre</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="FR">Le plan strat&#xE9;gique n&#x2019;est pas encore adapt&#xE9; au nouveau contexte &#xE9;pid&#xE9;miologique et financier. Un &#xE9;valuation externe de la pr&#xE9;sente strat&#xE9;gie est planifi&#xE9;e en 2020.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2017-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="FR">Le Plan d&#x2019;Action Strat&#xE9;gique est mis en &#x153;uvre</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">The approach of HAT control has been thoroughly reviewed, including rationalization,  and accepted by the donors, WHO and implementing partner PNLTHA</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator aggregation-status="0" ascending="1" measure="5">
    <title>
     <narrative xml:lang="FR">Niveau de connaissance sur comment surveiller les foyers de THA &#xE9;teints &#xE0; long terme</narrative>
    </title>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="FR">Manque de connaissance sur comment surveiller des foyers de THA &#xE9;teints &#xE0; long terme</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="FR">Un mod&#xE8;le de surveillance des foyers &#xE9;teints de THA a &#xE9;t&#xE9; d&#xE9;velopp&#xE9; et est valid&#xE9;</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">In order to achieve interruption of transmission, the current strategy of serological screening followed by a confirmation test, will be insufficient. During FA4, the pilot studies in Kimpese confirmed feasibility and potential of implementing more complex tests at centralized level. Based on these results, a new strategy has been introduced and approved, including surveillance of old focus in difficult accessible areas</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2017-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="FR">Donn&#xE9;es g&#xE9;n&#xE9;r&#xE9;es par le projet sur la performance de nouveaux outils de surveillance</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="FR">Un mod&#xE8;le de surveillance des foyers &#xE9;teints de THA a &#xE9;t&#xE9; d&#xE9;velopp&#xE9; et est valid&#xE9;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator aggregation-status="0" ascending="1" measure="5">
    <title>
     <narrative xml:lang="FR">Programme d&apos;assurance de qualit&#xE9; formel</narrative>
    </title>
    <description>
     <narrative xml:lang="FR"></narrative>
    </description>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="FR">Non-existence de programme d&#x2019;assurance de qualit&#xE9; formel</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="FR">La qualit&#xE9; du diagnostic THA et la qualit&#xE9; des donn&#xE9;es THA sont assur&#xE9;s selon le plan</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="FR">Le programme d&#x2019;assurance qualit&#xE9; se trouve dans une phase pilote dans les anciennes provinces de Bandundu. L&#x2019;impl&#xE9;mentation devra &#xEA;tre acc&#xE9;l&#xE9;r&#xE9;e afin de pouvoir atteindre l&#x2019;objectif.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2017-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="FR">La qualit&#xE9; du diagnostic THA et la qualit&#xE9; des donn&#xE9;es THA sont assur&#xE9;s selon le plan</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">The quality assurance for HAT diagnostics has been thoroughly reviewed and extended beyond follow-up of mobile teams. The new comprehensive strategy focuses on i) quality control of diangostic tests ii) internal quality control iii) external quality control and iv) Standard operation procedures. It involves the 3 Congolese partner institutions of ITM (PNLTHA, INRB, CRSK) but also ITM Antwerp, IRD and WHO.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
